ReviewJournal of clinical and translational hepatology2018

Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials.

James J Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.